These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3838772)

  • 1. Ocular manifestations of Graves' disease.
    J R Soc Med; 1985 May; 78(5):416-7. PubMed ID: 3838772
    [No Abstract]   [Full Text] [Related]  

  • 2. An evaluation of plasma exchange for Graves' ophthalmopathy.
    Kelly W; Longson D; Smithard D; Fawcitt R; Wensley R; Noble J; Keeley J
    Clin Endocrinol (Oxf); 1983 May; 18(5):485-93. PubMed ID: 6688205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Graves' ophthalmopathy with new immunosuppressive agents.
    Utech C; Wulle KG; Panitz N; Kiefer H
    Dev Ophthalmol; 1989; 20():94-9. PubMed ID: 2591632
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of Graves' ophthalmopathy with cyclosporin A.
    Kvetny J; Frandsen NE; Johnsen T; Dieperinck H; Mogensen E
    Acta Med Scand; 1986; 220(2):189-91. PubMed ID: 3535393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effects of intensive plasma exchange followed by immunosuppressive therapy in severe Graves' ophthalmopathy.
    Glinoer D; Etienne-Decerf J; Schrooyen M; Sand G; Hoyoux P; Mahieu P; Winand R
    Acta Endocrinol (Copenh); 1986 Jan; 111(1):30-8. PubMed ID: 2868602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effects of intensive plasma exchange followed by immunosuppressive therapy in severe Graves' ophthalmopathy.
    Glinoer D; Etienne-Decerf J; Schrooyen M; Sand G; Hoyoux P; Mahieu P; Winand R
    Metab Pediatr Syst Ophthalmol (1985); 1988; 11(3):133-40. PubMed ID: 3205168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effects of plasma exchange upon patients with malignant exophthalmos due to Graves' disease].
    Fukino O; Tamai H; Kimura T; Nakagawa T; Inaba S; Kuma K; Kubota K; Kuzuya N; Uchimura H; Nagataki S
    Nihon Naibunpi Gakkai Zasshi; 1983 Jan; 59(1):72-80. PubMed ID: 6687575
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma exchange therapy for severe Graves' ophthalmopathy.
    Glinoer D; Schrooyen M; Winand R
    Dev Ophthalmol; 1989; 20():91-3. PubMed ID: 2591631
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasma exchange in Graves' ophthalmopathy.
    De Rosa G; Menichella G; Della S; Rossi PL; Testa A; Pierelli L; Cecchini L; Callà C; Mango G
    Prog Clin Biol Res; 1990; 337():321-5. PubMed ID: 2191325
    [No Abstract]   [Full Text] [Related]  

  • 10. [Symposium: New therapeutic perspectives: autoimmunity in endocrinology].
    Ann Endocrinol (Paris); 1985; 46(4-5):343-5. PubMed ID: 3841797
    [No Abstract]   [Full Text] [Related]  

  • 11. [A clinical analysis of Graves' ophthalmopathy and ophthalmic Graves' disease].
    Liao ZQ
    Zhonghua Yan Ke Za Zhi; 1992 Jul; 28(4):236-9. PubMed ID: 1299571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of malignant Graves' ophthalmopathy with cyclosporin-A--a case report.
    Bakó G; Forizs E; Herczeg L; Kolozsvari L; Leövey A
    Radiobiol Radiother (Berl); 1987; 28(5):574-6. PubMed ID: 3441606
    [No Abstract]   [Full Text] [Related]  

  • 13. Graves' ophthalmopathy.
    Yeatts RP
    Med Clin North Am; 1995 Jan; 79(1):195-209. PubMed ID: 7808092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporin improves Graves' ophthalmopathy.
    Weetman AP; McGregor AM; Ludgate M; Beck L; Mills PV; Lazarus JH; Hall R
    Lancet; 1983 Aug; 2(8348):486-9. PubMed ID: 6136647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular manifestations of Graves' disease: therapeutic approaches.
    Day RM
    Bull N Y Acad Med; 1977 Apr; 53(3):277-9. PubMed ID: 266411
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunologic aspects of Graves' ophthalmopathy. Therapeutic role of plasma exchange].
    Morosini PP; Salvi A; Marchegiani G; Maniscalco L
    Minerva Endocrinol; 1984; 9(1):25-30. PubMed ID: 6548795
    [No Abstract]   [Full Text] [Related]  

  • 17. Cyclosporin A in management of Graves' disease.
    McGregor AM; Beck L; Hall R
    J R Soc Med; 1985 Jun; 78(6):511-2. PubMed ID: 3839019
    [No Abstract]   [Full Text] [Related]  

  • 18. Relationship between Graves' ophthalmopathy and type of treatment of Graves' hyperthyroidism.
    Marcocci C; Bartalena L; Bogazzi F; Bruno-Bossio G; Pinchera A
    Thyroid; 1992; 2(2):171-8. PubMed ID: 1525588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of severe Graves' ophthalmopathy with cyclosporin A.
    Utech C; Wulle KG; Bieler EU; Pfannenstiel P; Panitz N; Kiefer H
    Acta Endocrinol (Copenh); 1985 Dec; 110(4):493-8. PubMed ID: 3911714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ciclosporine and Graves' ophthalmopathy.
    Gayno JP; Strauch G
    Horm Res; 1987; 26(1-4):190-7. PubMed ID: 3596468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.